Clinical Trial: PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells

Brief Summary: The purpose of this study is to analyze the safety and feasibility of direct administration intrafemoral mesenchymal stem cells (MSCs) in vitro expanded autologous treatment of patients with femoral osteonecrosis.

Detailed Summary:
Sponsor: Red de Terapia Celular

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Red de Terapia Celular

Dates:
Date Received: October 2, 2012
Date Started: July 2012
Date Completion:
Last Updated: March 29, 2017
Last Verified: March 2017